These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 5511943

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [A chronic extrapyramidal syndrome as a complication of neuroleptic therapy].
    Gurovich IIa, Fleĭs EP.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(12):1862-8. PubMed ID: 5375563
    [No Abstract] [Full Text] [Related]

  • 3. [Late extrapyramidal hyperkineses after prolonged neuroleptic therapy].
    Hippius H, Lange J.
    Arzneimittelforschung; 1970 Jul; 20(7):888-90. PubMed ID: 5536050
    [No Abstract] [Full Text] [Related]

  • 4. [Paroxysmal extrapyramidal syndrome caused by taking neuroleptic drugs].
    Gurovich IIa, Fleĭs EP.
    Klin Med (Mosk); 1969 Sep; 47(9):132-7. PubMed ID: 5397873
    [No Abstract] [Full Text] [Related]

  • 5. A survey of extrapyramidal manifestations in the inpatient population of a psychiatric hospital.
    Lehmann HE, Ban TA, Saxena BM.
    Laval Med; 1970 Sep; 41(7):909-16. PubMed ID: 5509489
    [No Abstract] [Full Text] [Related]

  • 6. [On the problem of the terminal extrapyramidal hyperkineses as observed in 1600 patients during long-term therapy with neuroleptics].
    Degkwitz R, Wenzel W, Binsack KF, Herkert H, Luxenburger O.
    Arzneimittelforschung; 1966 Feb; 16(2):276-9. PubMed ID: 4861657
    [No Abstract] [Full Text] [Related]

  • 7. A survey of extrapyramidal manifestations in patients attending an after care clinic of a psychiatric hospital.
    Guttman H, Lehmann HE, Ban TA.
    Laval Med; 1970 Apr; 41(4):449-55. PubMed ID: 5515661
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Causes of persisting extrapyramidal hyperkinesis after prolonged administration of major tranquilizers].
    Degkwitz R.
    Act Nerv Super (Praha); 1967 Nov; 9(4):389-400. PubMed ID: 5612952
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Action of amantadine in extrapyramidal syndromes caused by neuroleptics].
    Fanali A, Nardini M, Sorgona F.
    Sist Nerv; 1970 Nov; 22(5):273-85. PubMed ID: 5514245
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Symptoms of the extrapyramidal syndrome during maintenence therapy with neuroleptic drugs].
    Sujecka-Szymkiewicz H.
    Psychiatr Pol; 1967 Nov; 1(1):79-84. PubMed ID: 4876412
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Post-neuroleptic late dyskinesia].
    Villeneuve A, Lavallée JC, Lemieux LH.
    Laval Med; 1969 Nov; 40(9):832-7. PubMed ID: 5366584
    [No Abstract] [Full Text] [Related]

  • 17. Clinical and ergotherapeutic evaluation of fluspirilene (R 6218), a long-acting injectable neuroleptic, in chronic psychotic patients.
    Tanghe A, Vereecken JL.
    Psychiatr Neurol Neurochir; 1971 Nov; 74(5):379-89. PubMed ID: 5138128
    [No Abstract] [Full Text] [Related]

  • 18. [On the mode of action and the question of central organic late damages of continuous neuroleptic treatment].
    Haddenbrock S.
    Nervenarzt; 1966 May; 37(5):199-203. PubMed ID: 5298253
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.